Education
About Us
Working with TipRanks
Follow Us
Verve Therapeutics (VERV)
NASDAQ:VERV
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 32.33M | $ 11.76M | $ 1.94M | $ 0.00 | $ 0.00 |
| Gross Profit | $ 32.33M | $ 6.30M | $ -4.77M | $ -3.38M | $ -1.33M |
| Operating Income | $ -228.66M | $ -223.12M | $ -165.69M | $ -87.07M | $ -40.63M |
| EBITDA | $ -228.66M | $ -217.67M | $ -162.88M | $ -85.53M | $ -39.30M |
| Net Income | $ -198.71M | $ -200.07M | $ -157.39M | $ -118.64M | $ -45.54M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 524.28M | $ 623.95M | $ 554.81M | $ 360.44M | $ 72.11M |
| Total Assets | $ 647.39M | $ 752.69M | $ 679.22M | $ 384.12M | $ 78.41M |
| Total Debt | $ 69.98M | $ 74.91M | $ 81.92M | $ 1.96M | $ 125.16M |
| Net Debt | $ -102.58M | $ -131.27M | $ -33.49M | $ -62.38M | $ 116.17M |
| Total Liabilities | $ 153.99M | $ 153.19M | $ 128.29M | $ 26.77M | $ 142.32M |
| Stockholders' Equity | $ 493.40M | $ 599.50M | $ 550.93M | $ 357.35M | $ -63.91M |
| Cash Flow | |||||
| Free Cash Flow | $ -161.43M | $ -158.83M | $ -135.56M | $ -82.24M | $ -38.69M |
| Operating Cash Flow | $ -157.69M | $ -149.55M | $ -122.33M | $ -77.88M | $ -35.27M |
| Investing Cash Flow | $ 74.88M | $ 27.69M | $ -155.96M | $ -239.10M | $ -51.13M |
| Financing Cash Flow | $ 49.20M | $ 212.58M | $ 328.96M | $ 377.09M | $ 92.63M |